A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

NCT01337518 · clinicaltrials.gov ↗
PHASE1
Phase
SUSPENDED
Status
150
Enrollment
INDUSTRY
Sponsor class

Stopped Reassessment of strategic direction

Conditions

Interventions

Sponsor

Enzon Pharmaceuticals, Inc.